{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:58:29Z","timestamp":1786121909203,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["ZDSYS20200810171403013"],"award-info":[{"award-number":["ZDSYS20200810171403013"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["RCJC20200714114436049"],"award-info":[{"award-number":["RCJC20200714114436049"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971507"],"award-info":[{"award-number":["81971507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303714"],"award-info":[{"award-number":["82303714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:45Z","timestamp":1778760465000},"page":"4814-4827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic application of IL-33 for cancer immunoprevention and immunotherapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2590-1020","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9746-2938","authenticated-orcid":false,"given":"Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.05.009_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.05.009_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","article-title":"Emerging Functions of IL-33 in Homeostasis and Immunity","volume":"40","author":"Dwyer","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ni.3370","article-title":"Interleukin 33 is a guardian of barriers and a local alarmin","volume":"17","author":"Martin","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155961","article-title":"IL-33 biology in cancer: An update and future perspectives","volume":"157","author":"Yeoh","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.ymthe.2026.05.009_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41590-020-0745-y","article-title":"ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung","volume":"21","author":"Schuijs","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.4049\/jimmunol.1800173","article-title":"Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression","volume":"201","author":"Long","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.009_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122375","article-title":"Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis","volume":"3","author":"Andersson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.05.009_bib11","article-title":"The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.009_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay1813","article-title":"Tumor-initiating cells establish an IL-33-TGF-beta niche signaling loop to promote cancer progression","volume":"369","author":"Taniguchi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.05.009_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.1401344","article-title":"Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells","volume":"194","author":"Gao","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4049\/jimmunol.1501399","article-title":"Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer","volume":"198","author":"Dominguez","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41590-019-0321-5","article-title":"Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth","volume":"20","author":"Hollande","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.009_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41590-021-00943-z","article-title":"Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma","volume":"22","author":"Jacquelot","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T Cells and Human Disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.05.009_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib23","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1158\/1078-0432.CCR-10-2805","article-title":"Prognostic immune markers in non-small cell lung cancer","volume":"17","author":"Suzuki","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.05.009_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13058-021-01403-0","article-title":"Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression","volume":"23","author":"Stenstr\u00f6m","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2026.05.009_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-020-0296-3","article-title":"Modulation of regulatory T cell function and stability by co-inhibitory receptors","volume":"20","author":"Lucca","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in T(reg) cell-mediated tumor immunoevasion","volume":"21","author":"Hatzioannou","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-gamma Drives T(reg) Fragility to Promote Anti-tumor Immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","article-title":"IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival","volume":"187","author":"Turnquist","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A Distinct Function of Regulatory T Cells in Tissue Protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1215418","article-title":"The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses","volume":"335","author":"Bonilla","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.05.009_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41590-023-01697-6","article-title":"A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses","volume":"25","author":"Brunner","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib36","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.05.009_bib37","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3389\/fimmu.2019.01833","article-title":"Memory CD8(+) T Cell Protection From Viral Reinfection Depends on Interleukin-33 Alarmin Signals","volume":"10","author":"Baumann","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.1701757","article-title":"IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine","volume":"202","author":"McLaren","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib39","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/s41590-024-01970-2","article-title":"Vaccination against rapidly evolving pathogens and the entanglements of memory","volume":"25","author":"Cobey","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib40","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ymthe.2026.05.009_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41423-022-00918-6","article-title":"Emerging roles of ILC2s in antitumor immunity","volume":"19","author":"Li","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2021.01.002","article-title":"ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8(+) T cells","volume":"502","author":"Wan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.05.009_bib43","article-title":"Type 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.05.009_bib44","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190706","article-title":"The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses","volume":"217","author":"Arnold","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201234","article-title":"T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation","volume":"218","author":"Hemmers","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add7399","article-title":"Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.05.009_bib47","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib48","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1038\/s41467-025-61647-8","article-title":"ST2\/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche","volume":"16","author":"Jiang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.009_bib49","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.05.009_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri.2017.140","article-title":"The dawn of vaccines for cancer prevention","volume":"18","author":"Finn","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib51","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.18632\/aging.102707","article-title":"The Interleukin-33\/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation","volume":"12","author":"Lin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ymthe.2026.05.009_bib52","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-13-2729","article-title":"Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity","volume":"74","author":"Villarreal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.05.009_bib53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/s12276-024-01249-4","article-title":"IL-33 and IL-33-derived DC-based tumor immunotherapy","volume":"56","author":"Kang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib54","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41467-021-25057-w","article-title":"Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment","volume":"12","author":"Ring","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.009_bib55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.009_bib57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2026.05.009_bib58","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/2326-6066.CIR-18-0066","article-title":"Treg Fragility: A Prerequisite for Effective Antitumor Immunity?","volume":"6","author":"Overacre-Delgoffe","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.05.009_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123919","article-title":"IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.05.009_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1527497","article-title":"IL-33 increases ST2(+) Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner","volume":"8","author":"Halvorsen","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2026.05.009_bib61","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1172\/JCI89717","article-title":"ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence","volume":"127","author":"Chevalier","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.05.009_bib62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.009_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","article-title":"Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor","volume":"38","author":"Zaiss","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.05.009_bib64","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.05.009_bib65","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.4049\/jimmunol.1501730","article-title":"Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth","volume":"196","author":"Kim","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib66","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","article-title":"Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1101270","article-title":"Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity","volume":"188","author":"Ikutani","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib68","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-14-2379","article-title":"Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment","volume":"75","author":"Zaynagetdinov","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.05.009_bib69","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.celrep.2015.08.033","article-title":"TNF Counterbalances the Emergence of M2 Tumor Macrophages","volume":"12","author":"Kratochvill","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.05.009_bib70","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41568-020-0283-9","article-title":"A new dawn for eosinophils in the tumour microenvironment","volume":"20","author":"Grisaru-Tal","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.05.009_bib71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ni.3159","article-title":"Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells","volume":"16","author":"Carretero","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.009_bib72","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.05.009_bib73","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1317420","article-title":"IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils","volume":"6","author":"Lucarini","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2026.05.009_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111664","article-title":"IL-33 Promotes CD11b\/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing","volume":"11","author":"Andreone","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.05.009_bib75","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41596-018-0016-7","article-title":"Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry","volume":"13","author":"Han","year":"2018","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:54:59Z","timestamp":1786085699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626003965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626003965"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic application of IL-33 for cancer immunoprevention and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}